These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta. Galicka A, Wolczyñski S, Anchim T, Surazyñski A, Lesniewicz R, Palka J. Eur J Biochem; 2001 Apr; 268(7):2172-8. PubMed ID: 11277941 [Abstract] [Full Text] [Related]
26. Prolidase in human breast cancer MCF-7 cells. Palka JA, Phang JM. Cancer Lett; 1998 May 15; 127(1-2):63-70. PubMed ID: 9619859 [Abstract] [Full Text] [Related]
27. Phosphorylation of prolidase increases the enzyme activity. Surazyński A, Pałka J, Wołczyński S. Mol Cell Biochem; 2001 Apr 15; 220(1-2):95-101. PubMed ID: 11451388 [Abstract] [Full Text] [Related]
28. Ex vivo evaluation of prolidase loaded chitosan nanoparticles for the enzyme replacement therapy. Colonna C, Conti B, Perugini P, Pavanetto F, Modena T, Dorati R, Iadarola P, Genta I. Eur J Pharm Biopharm; 2008 Sep 15; 70(1):58-65. PubMed ID: 18547793 [Abstract] [Full Text] [Related]
30. Inhibition of prolidase activity by non-steroid antiinflammatory drugs in cultured human skin fibroblasts. Miltyk W, Karna E, Pałka J. Pol J Pharmacol; 1996 Sep 15; 48(6):609-13. PubMed ID: 9112701 [Abstract] [Full Text] [Related]
31. Characteristics of partially purified prolidase and prolinase from the human prostate. Masuda S, Watanabe H, Morioka M, Fujita Y, Ageta T, Kodama H. Acta Med Okayama; 1994 Aug 15; 48(4):173-9. PubMed ID: 7817771 [Abstract] [Full Text] [Related]
32. In situ activation of human erythrocyte prolidase: potential for enzyme replacement therapy in prolidase deficiency. Hechtman P, Richter A, Corman N, Leong YM. Pediatr Res; 1988 Dec 15; 24(6):709-12. PubMed ID: 3205627 [Abstract] [Full Text] [Related]
33. Characterization of fibroblast-derived prolidase. The presence of two forms of prolidase. Oono T, Yasutomi H, Ohhashi T, Kodama H, Arata J. J Dermatol Sci; 1990 Sep 15; 1(5):319-23. PubMed ID: 2073490 [Abstract] [Full Text] [Related]
34. Plasma prolidase and prolinase activity in prolidase deficiency. Myara I, Stalder JF. Clin Chem; 1986 Mar 15; 32(3):562. PubMed ID: 3948414 [No Abstract] [Full Text] [Related]
35. Characteristics and partial purification of prolidase and prolinase from leukocytes of a normal human and a patient with prolidase deficiency. Kodama H, Ohhashi T, Ohba C, Ohno T, Arata J, Kubonishi I, Miyoshi I. Clin Chim Acta; 1989 Mar 15; 180(1):65-72. PubMed ID: 2743570 [No Abstract] [Full Text] [Related]
36. Clinical and biochemical characteristics of prolidase deficiency in siblings. Freij BJ, Levy HL, Dudin G, Mutasim D, Deeb M, Der Kaloustian VM. Am J Med Genet; 1984 Nov 15; 19(3):561-71. PubMed ID: 6507502 [Abstract] [Full Text] [Related]
37. Prolidase deficiency among an Israeli population: prenatal diagnosis in a genetic disorder with uncertain prognosis. Mandel H, Abeling N, Gutman A, Berant M, Scholten EG, Sheiman C, Luder A, van Gennip AH. Prenat Diagn; 2000 Nov 15; 20(11):927-9. PubMed ID: 11113899 [Abstract] [Full Text] [Related]
38. Prolidase deficiency: characteristics of human skin fibroblast prolidase using colorimetric and fluorimetric assays. Priestman DA, Butterworth J. Clin Chim Acta; 1984 Sep 29; 142(2):263-71. PubMed ID: 6499208 [No Abstract] [Full Text] [Related]
39. Is there any role of prolidase enzyme activity in the etiology of preeclampsia? Pehlivan M, Ozün Ozbay P, Temur M, Yılmaz O, Verit FF, Aksoy N, Korkmazer E, Üstünyurt E. J Matern Fetal Neonatal Med; 2017 May 29; 30(9):1108-1113. PubMed ID: 27333996 [Abstract] [Full Text] [Related]
40. Prolidase and prolinase activities in moderately and poorly differentiated lung adenocarcinoma. Karna E, Pałka J, Chyczewski L, Słodkowska J, Bogdan J. Rocz Akad Med Bialymst; 1997 May 29; 42 Suppl 1():230-40. PubMed ID: 9337540 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]